Molecular Staging, Inc.

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

162 documents for Molecular Staging, Inc.

- Protedyne's BioCube System Passes Acceptance at Molecular Staging Inc.; Automation Earmarked to Accelerate Protein BioChip Processing Service.
Business Editors/Health/Medical Writers WINDSOR, Conn.--(BUSINESS WIRE)--Feb. 4, 2003 Protedyne Corporation announced today the successful install...
- Business Wire
- February 04, 2003
- exclusive, exclusive, or partially exclusive: Molecular Staging, Inc.,
- FR, May 13, 2002
- Notices
- Agricultural Research Service
- Molecular Insight Pharmaceuticals, Inc. Initiates Trofex(TM) Phase 1 Trial for the Detection and Staging of Metastatic Prostate Cancer.
- Marks Company's Fourth Clinical-stage Program and Third in Cancer - CAMBRIDGE, Mass. -- Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) ann...
- Business Wire
- June 12, 2008

- Paper published in Genome Research describes a procedure for rapid amplification of circular DNA developed by Molecular Staging Inc. and Amersham Pharmacia Biotech.
Health/Medical Editors BIOWIRE2K NEW HAVEN, Conn.--(BW HealthWire)--Aug. 13, 2001 Molecular Staging Inc., today announced that, together with Am...
- Business Wire
- August 13, 2001
- Molecular Insight Pharmaceuticals, Inc. Presents Three Studies on Trofex(TM) Program for Prostate Cancer Diagnosis and Staging.
Studies Formed Basis for Recently Initiated Clinical Trial CAMBRIDGE, Mass. -- Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) today announce...
- Business Wire
- June 18, 2008
- Molecular Staging Inc Granted a U.S. Patent Covering Multiple Displacement Amplification -MDA-.
Business Editors & Health/Medical Writers NEW HAVEN, Conn.--(BW HealthWire)--Sept. 11, 2001 Molecular Staging Inc. (MSI) announced today that it h...
- Business Wire
- September 11, 2001
- Molecular Staging Inc. Awarded Six U.S. Patents and Three International Patents.
Health/Medical Editors NEW HAVEN, Conn.--(BW HealthWire)--Sept. 5, 2001 - Patents Issued in US, Europe, and Australia further expands Molecular ...
- Business Wire
- September 05, 2001
- Molecular Staging Inc. Announces a Number of Recent Additions to Its Senior Management Team.
Business Editors & Health/Medical Writers BIOWIRE2K NEW HAVEN, Conn.--(BW HealthWire)--May 29, 2001 Molecular Staging Inc., a technology leader ...
- Business Wire
- May 29, 2001
- Molecular Staging Inc. Awarded Two Additional Patents For Rolling Circle Amplification Technology.
Business Editors/Medical & Bioscience Writers NEW HAVEN, Conn.--(BW HealthWire)--Sept. 27, 2001 Molecular Staging Inc. (MSI) announced today that ...
- Business Wire
- September 27, 2001
- Molecular Staging Inc. Announces Appointment Of Dr. Richard Barker as Executive Chairman Of the Company's Board of Directors.
Business Editors/Health/Medical Writers NEW HAVEN, Conn.--(BUSINESS WIRE)--Jan. 20, 2004 Molecular Staging Inc. (MSI) today announced the appointm...
- Business Wire
- January 20, 2004